Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000712130 | SCV000225401 | uncertain significance | not provided | 2015-04-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000712130 | SCV000525358 | likely benign | not provided | 2020-03-17 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001088258 | SCV000563661 | likely benign | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2024-01-07 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000712130 | SCV000842552 | benign | not provided | 2018-05-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372084 | SCV002687158 | benign | Inborn genetic diseases | 2020-10-02 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003955023 | SCV004772888 | likely benign | KCNT1-related disorder | 2019-09-04 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |